Robert W. Duggan - Dec 11, 2023 Form 4 Insider Report for Pulse Biosciences, Inc. (PLSE)

Role
Director, 10%+ Owner
Signature
/s/ Kenneth B. Stratton, as Attorney-in-Fact
Stock symbol
PLSE
Transactions as of
Dec 11, 2023
Transactions value $
$843,504
Form type
4
Date filed
12/13/2023, 06:03 PM
Previous filing
Dec 12, 2023
Next filing
Dec 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PLSE Common Stock Purchase $844K +90.1K +0.24% $9.36 37M Dec 11, 2023 Direct F1
holding PLSE Common Stock 352K Dec 11, 2023 See footnote F2
holding PLSE Common Stock 492K Dec 11, 2023 See footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Volume-weighted average price.
F2 Shares are held by Blazon Corporation, of which the Reporting Person is the majority shareholder.
F3 Shares are held by Genius Inc., of which the Reporting Person is the sole shareholder.